Oxazetidine derivatives, process for preparing them and use in human medicine and in cosmetics
US9353083B2 · kind B2 · utility
1Cited by
1References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 28, 2012 |
| Grant date | May 31, 2016 |
| Priority date | — |
| Expiry date | Jun 28, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating hypopigmentary pathologies and photosensitive dermatoses are described. Also described, are compounds that are agonists of the MCIR receptor and that exhibit reduced toxicity relative to other compounds of the same class. These compounds can have the general formula (I) wherein: R1 represents a cyclopropylmethyl or a 4-hydroxybutyl group; R2 represents a hydrogen atom or a methyl group; and also the salts and enantiomers of the corresponding compounds of general formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.